Ahmedabad

That was real traffic of candidates on GPAT-TUTOR Platform for OCF 2011's test-2. The no. of candidates participating in OCF competition is increased for TEST-2. The test was much easier than test -1 and passing percentage was 50 % ... But Let me tell you very few of you cross that margin. But don’t worry as in GPAT if you would score atleast 35-40 %, you can qualify the pharma giant entrance.

Torrent Pharmaceuticals Limited, is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Torrent Pharma’s competitive advantage as a manufacturer stems from its world-class manufacturing facilities.

Students from around 190 different colleges of India were registered for first test of OCF - 2011. And average result was poor for this test... Many of the participants failed to cross even 50 % marks. But no need to worry Test - 2 is waiting for you all. It will be on 21^st August, 2011

In an urge to provide quality pharma education online, PharmaTutor.org has decided to conduct an online competition focusing various pharma entrance exams such as GPAT, NIPER-JEE, CET, MAHE, Bits-exam, NMAT and others.

June 2011

The Institute of Pharmacy has been established with a view to promote excellence in pharmaceutical education and to prepare young men and women to meet the challenges in the area of pharmaceutical industries, education, research and development and marketing. We aim to provide degree, postgraduate, doctoral and postdoctoral level education at this centre of excellence. The pharmacy profession in Gujarat and western part of India has been striving for such a centre and establishment of IP.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.